Showing results (171-180 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 17, 2004
Rhabdomyosarcomas are potential target of MAGE-specific immunotherapiesSilvia Tanzarella, Ilaria Lionello, Barbara Valentinis, et al.Cancer Immunology, Immunotherapy : CII|November 8, 2003
Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEAGustav J Ullenhag, Jan Fagerberg, Karin Strigård, et al.Cancer Immunology, Immunotherapy : CII|February 6, 2004
CD44v6: a target for antibody-based cancer therapyKarl-Heinz Heider, Hartmut Kuthan, Gerd Stehle, et al.Cancer Immunology, Immunotherapy : CII|February 11, 2004
Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinomaHalina Kusnierczyk, Elzbieta Pajtasz-Piasecka, Jan-Willem Koten, et al.Cancer Immunology, Immunotherapy : CII|June 9, 2004
Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancerHaruko Yamaji, Toshihiko Iizasa, Eitetsu Koh, et al.Cancer Immunology, Immunotherapy : CII|March 5, 2004
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysateR Vilella, D Benítez, J Milà, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Low-dose recombinant interleukin-2 and low-dose cyclophosphamide in metastatic breast cancerD V Spicer, A Kelley, R Herman, et al.Cancer Immunology, Immunotherapy : CII|June 9, 2004
Both soluble and membrane-bound forms of Flt3 ligand enhance tumor immunity following "suicide" gene therapy in a murine colon carcinoma modelAbdul-Razzak Alsheikhly, Jehad Zweiri, Alice J Walmesley, et al.Cancer Immunology, Immunotherapy : CII|June 9, 2004
Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinomaJan Schmidt, Sven Eisold, Markus W Büchler, et al.Cancer Immunology, Immunotherapy : CII|May 6, 2004
Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?Raquel Tarazona, Javier G Casado, Rocío Soto, et al.Pageof 650